Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer (Liquid Biopsy)

Gustave Roussy

Status: Unknown

Conditions: Metastatic Cancer

Treatments: Procedure: Blood samples

Study type: Interventional

Funder types: Other

Identifiers

NCT02666612

2008-A00585-50

2008/1370 (Other Identifier)

Details and patient eligibility

About

Monitoring of circulating endothelial cells (CEC and mature cells called progenitors called CEP) or circulating tumor cells (CTC) in adult patients with metastatic cancer, possibly treated with targeted therapy.

Enrollment: 2,240 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with metastatic solid tumor
• Age> 18 years
• Signed consent

Exclusion criteria

• Patients with diseases associated with vascular lesions known.
• Patients protected by law, in accordance with Articles L1121-5 to L1121-8 of the Code of Public Health.
• Mental pathology that can interfere with the proper conduct of the study.
• Refusal of consent.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

2,240 participants in 1 patient group

Patients with metastatic cancer

Other group

Treatment:

Procedure: Blood samples